| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |